Related Experiment Video
Updated: Mar 22, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon
Bertrand Hugo Mbatchou Ngahane1, Junior Nouyep2, Malea Nganda Motto3
1Department of Internal Medicine, Douala General Hospital, Douala, Cameroon; Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Pulmonary tuberculosis survivors frequently experience lung function impairment. Longer symptom duration and fibrotic patterns are key risk factors, highlighting the need for early diagnosis to mitigate long-term respiratory effects.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Epidemiology
Background:
- Pulmonary tuberculosis (pTB) survivors often face lasting lung function impairment, impacting quality of life.
- Understanding the prevalence and risk factors of this impairment is crucial for patient management.
Purpose of the Study:
- To determine the prevalence of lung function impairment in patients treated for pTB.
- To identify factors associated with lung function impairment post-pTB treatment.
Main Methods:
- A cross-sectional study involving 269 pTB patients (aged ≥15) treated between 2008-2012 in Douala, Cameroon.
- Spirometric measurements assessed airflow obstruction, restrictive defects, and mixed defects.
- Logistic regression analysis identified independent risk factors for lung function impairment.
Main Results:
- The prevalence of lung function impairment was 45.4% among treated pTB patients.
- Independent risk factors identified were longer duration of symptoms before diagnosis (OR 1.08) and fibrotic radiographic patterns (OR 3.54).
Conclusions:
- Lung function impairment is a common consequence of pTB in Douala.
- Early healthcare-seeking for pTB symptoms is recommended to reduce the long-term impact on lung function.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

